TAKAKO FUJIWARA

Research field (1)： Internal medicine - General

Research theme for competitive and other funds (12)：

2006 - 2007 エリスロポエチンは非虚血性心筋症にも有効である
2004 - 2005 骨髄抑制剤併用G-CSF療法は心筋梗塞組織の再生を促進し、心機能を著明に改善する
2002 - 2003 拡張型心筋症ハムスターに対する自家骨髄幹細胞移植
2000 - 2001 心筋細胞のアポトーシスの全プロセスは10分から20分で極めて短時間である-個々の培養心筋細胞の形態・機能(収縮・拡張)の顕微鏡ビデオを用いた48時間連続撮影)
1996 - 心筋梗塞におけるアポトーシスの発現とその意義 - ウサギ心筋梗塞モデルにおけるアポトーシスの抑制因子・促進因子およびそれらの遺伝子解析 -

Show all

Papers (28)：

ｍore...

Lectures and oral presentations (21)：

Preceding starvation prevents acute doxorubicin cardiotoxity via autophagy activation.
(European Heart Journal. 33 (Abstract Supplement), 682. 2012)
The ratio of visceral fat area to subcutaneous fat area measured by computed tomography is a stronger predictor of coronary stenosis than simple visceral fat area.
(European Heart Journal. 32 (Abstract Supplement), 533. 2011)
Deletion of LOX-1 resulted in suppression of angiogenesis in ischemic hindlimb tissue.
(European Heart Journal. 32 (Abstract Supplement), 316. 2011)
Deletion of DOX-1 protects against doxorubin-induced cardiomyopathy.
(European Heart Journal. 32 (Abstract Supplement), 1096. 2011)
Asialoerythropoietin, a nonerythropoietic derivative of erythropoietin, displays broad anti-heart failure activity.
(European Heart Journal. 32 (Abstract Supplement), 662-663. 2011)

ｍore...

Education (1)：

Professional career (1)：

Work history (1)：

2012/04/01 - 現在 Sonoda Women's University Faculty of Human Health, Department of Food and Nutrition

Committee career (1)：

Association Membership(s) (1)：

Japan Society for tobacco control

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page